Excitation of the brain constitute one of the distinguishing features of REM sleep. stem pedunculopontine tegmentum cholinergic cells induces wake-Brain stem cholinergic mechanisms have long been thought fulness and REM sleep. J. Neurophysiol. 77: 2975-2988, 1997 to play a major role in the generation of REM sleep, cortical Considerable evidence suggests that brain stem pedunculopontine activation, and the genesis of PGO waves (Datta 1995(Datta , 1997 tegmentum (PPT) cholinergic cells are critically involved in the Gillin et al. 1985; Jones 1991; Morrison 1979; Vanderwolf normal regulation of wakefulness and rapid eye movement (REM) 1988). The cholinergic hypothesis of REM sleep generation sleep. However, much of this evidence comes from indirect studies. comes from microinjection studies showing that centrally Thus, although involvement of PPT cholinergic neurons has been administered cholinomimetics evoke a state that is behaviorsuggested by numerous investigations, the excitation of PPT choally and electrophysiologically similar to REM sleep (Baglinergic neurons causal to the behavioral state of wakefulness and REM sleep has never been directly demonstrated. In the present hdoyan et al. Datta et al. 1992; Gnadt and Pegram study we examined the effects of three different levels of activation 1986; Hernandez-Peon et al. 1962). Furthermore, spontaneof PPT cholinergic cells in wakefulness and sleep behavior. The ous release of acetylcholine (ACh) in the pontine reticular effects of glutamate on the activity of PPT cholinergic cells were formation is greater during REM sleep than it is during studied by microinjection of one of the three different doses of Lwaking (W) and S (Kodama et al. 1990; Lydic et al. 1991 ). glutamate (0.3, 1.0, and 3.0 mg) or saline (vehicle control) into The concept of a brain stem cholinergic mechanism in cortithe PPT cholinergic cell compartment while quantifying the effects 2975 0022-3077/97 $5.00
cal activation was first proposed by Shute and Lewis (1967) on wakefulness and sleep in free moving chronically instrumented and has been supported by many pharmacological studies cats. All microinjections were made during wakefulness and were followed by 4 h of recording. Polygraphic records were scored for (reviewed in Datta 1995; Vanderwolf 1988) . The hypothesis wakefulness, slow-wave sleep states 1 and 2, slow-wave sleep that the brain stem cholinergic system contributes to neocorwith pontogeniculooccipital waves, and REM sleep. Dependent tical activation receives additional support from the finding variables quantified after each microinjection included the percentthat the levels of ACh in the thalamus are higher during the age of recording time spent in each state, the latency to onset of cortically activated states of W and REM sleep than they REM sleep, the number of episodes per hour for REM sleep, and are during S (Williams et al. 1994) . Like REM sleep and the duration of each REM sleep episode. A total of 48 microinjeccortical activation, the role of cholinergic mechanisms in the tions was made into 12 PPT sites in six cats. Microinjection of generation of PGO wave activity was also demonstrated by 0.3-and 1.0-mg doses of L-glutamate into the cholinergic cell compartment of the PPT increased the total amount of REM sleep in studies involving systemic and intracerebral injection of choa dose-dependent manner. Both doses of L-glutamate increased linergic agents (Datta et al. 1991 (Datta et al. -1993 Henriksen et al. REM sleep at the expense of slow-wave sleep but not wakefulness. 1972; Jacobs et al. 1972; Magherini et al. 1971 ; Ruch-Mona-Microinjection of 3.0 mg L-glutamate kept animals awake for 2- chon et al. 1976) . Taken together, these results strongly 3 h by eliminating slow-wave and REM sleep. The results show support the suggestion that ACh is involved in the generation that the microinjection of the excitatory amino acid L-glutamate of REM sleep, cortical activation, and the genesis of PGO into the PPT cholinergic cell compartments can increase wakewaves. fulness and/or REM sleep depending on the L-glutamate dosage.
Identification of brain stem cholinergic neurons in the These findings unambiguously confirm the hypothesis that the excipedunculopontine tegmentum (PPT) has generated a new tation of the PPT cholinergic cells is causal to the generation of wakefulness and REM sleep. impetus to study the direct involvement of PPT neurons in the generation of REM sleep, cortical activation, and the genesis of PGO waves (Mesulam et al. 1983 (Mesulam et al. , 1984 (Mesulam et al. , 1989  I N T R O D U C T I O N . Recent brain stem lesion studies have demonstrated that lesions of Rapid eye movement (REM) sleep is a distinctive sleep the PPT cholinergic neurons reduced and/or eliminated stage that alternates periodically with episodes of slow-wave REM sleep, cortical activation, muscle atonia during REM sleep (S) and is normally preceded by periods of S in which sleep, and PGO waves (Datta and Hobson 1995; Shouse and pontogeniculooccipital (PGO) waves become apparent dur-Siegel 1992; Webster and Jones 1988) . Electrical stimulaing the transition from S to REM sleep. PGO waves are tion of the PPT causes increased ACh release in the cholinophasic field potentials recorded from the pontine tegmentum, lateral geniculate body, and occipital cortex. These waves ceptive REM-sleep-generating region of the pontine reticular to 02.5 ) (Berman 1968 ) as described previously ( Datta et al. formation (Lydic and Baghdoyan 1993) . Recordings from 1992 ) . The tips of the guide tubes were left 5 mm above the the PPTs of behaving cats have identified several different targets to minimize cellular damage at the injection sites ( Bagclasses of neurons whose firing rates correlate with REM hdoyan et al. 1993; Datta et al. 1992 ) . sleep, cortical activation, and PGO waves (Datta 1995 (Datta , 1997 Datta and Hobson 1994; Datta et al. 1989; El-Mansari et al. Postsurgical treatment 1989; McCarley et al. 1978; Nelson et al. 1983; Sakai and Jouvet 1980; Steriade et al. 1990 ). Some tonically discharg-Cats were treated with butorphanol (0.4 mg/kg im) every 6 h ing PPT neurons called REM-ON cells progressively increase for ¢24 h postsurgery to control any possible pain on recovery their firing rates as the animal moves from wakefulness to from anesthesia. To prevent possible infection due to surgery, the cats were also treated with amoxicillin (10 mg/kg sc) immediately S and then to REM sleep. Other PPT neurons called Wafter surgery and for 5 days postoperatively (5 mg/kg po).
REM-ON cells are tonically active during both cortically activated states of W and REM sleep. A small population of REM-ON and W-REM-ON cells discharges phasically with Adaptation to recording conditions phasic PGO waves (called PGO-ON cells). Collectively Seven to 10 days after recovery from surgery, cats were adapted these observations suggest that the PPT and its neurotransfor 2-3 wk to the free-moving polygraphic recording conditions mitter ACh are involved in the generation of REM sleep, (size of recording cage: 4 1 2 1 2 ft) before microinjection sescortical activation, and the genesis of PGO waves. There is sions began. After Ç2 -3 wk of adaptation, cats were able to sleep no single study that directly shows that the excitation of PPT in the laboratory for recording sessions ¢4 h in duration (between cholinergic cells is causal to the generation of REM sleep, 12:00 and 16:00 h). The endpoints of adaptation recording sessions were determined when animals showed a consistent REM sleep cortical activation, and the genesis of PGO waves. latency and total REM sleep duration for at least three consecutive
In the present study we examined the hypothesis that the recording sessions. activation of PPT cells is causal to the generation of REM sleep and cortical activation. This was tested by microinjec-Intracerebral microinjections and experimental design tion of the excitatory amino acid L-glutamate into the PPT while simultaneously quantifying wake-sleep signs. Three After the adaptation recording sessions, microinjection sessions different levels of activation of PPT cells were achieved began. The microinjection procedure has been previously described by varying the concentration of injected L-glutamate to see in detail (Baghdoyan et al. 1993; Datta et al. 1992) . Briefly, microwhether different levels of activation cause different behavinjections were always made during wakefulness, and the cats were iors (Mayer and Westbrook 1987) . head restrained for the 3-5 min necessary for microinjection as previously described (Datta and Hobson 1994) . Four-hour control recording sessions were begun after a single, unilateral microinjec-
tion of 0.25 ml saline into the PPT. All microinjections were made with a 32-gauge stainless steel injector cannula that was 5 mm Animals longer than the implanted guide tube. On completion of the micro-Six male cats weighing 2.5-3.5 kg were used for these experiinjection procedure, cats were released from head restraint and ments. The animals were kept under regular lighting conditions placed in the recording chamber, where they were free to move, (light on at 7:00 h and off at 19:00 h) in a temperature-controlled eat, and drink. Polygraphic variables were recorded continuously environment, with free access to food and water. Principles for the for 4 h beginning at the onset of injection, and behavior was care and use of laboratory animals in research, as outlined by the observed on a video monitor. Two days after the control recording, National Institutes of Health (1985), were strictly followed. a single dose of monosodium L-glutamate (0.3, 1.0, or 3.0 mg in 0.25 ml sterile saline) was injected unilaterally into the control saline injection site with the use of the same injector cannula. After Surgical procedure microinjections of glutamate, cats were placed in the recording chamber and polygraphic variables were recorded continuously for Treatment of the animals and surgical procedures were in accordance with an approved animal welfare protocol. Cats were 4 h. Glutamate microinjections and recordings were made during the same 4-h period as control recordings (12:00-16:00 h) to first sedated with acepromazine ( 0.1 mg / kg im) and then anesthetized with inhaled halothane (2.0 -3.0% in O 2 ) . With the use of quantify the glutamatergic stimulation effects at the same point in the circadian cycle. Each PPT site received one control saline and sterile procedures, a standard set of recording electrodes was chronically implanted to objectively measure states of sleep and three glutamate microinjections in four different recording sessions 48 h apart. In six cats, a total of 12 PPT sites was microinjected wakefulness ( Ursin and Sterman 1981 ) . Stainless steel bilateral guide tubes were also implanted to permit directed intracranial (1 in the left and the other in the right side of each cat; for a summary of the sequence of injections see Table 1 ). In 4 of those drug administration. Bipolar electrodes were implanted in the skull over the frontal and parietal cortices to record the electroen-12 sites, glutamate microinjection doses were arranged in the following order: 0.3, 1.0, and 3.0 mg. In another four sites, the se-cephalogram ( EEG ) and in the posterior orbital bone to record the electrooculogram ( EOG ) . Multipolar electrodes were implanted quence of glutamate microinjection doses was 1.0, 3.0, and 0.3 mg.
The other four sites received 3.0, 0.3, and 1.0 mg. In 6 of those 12 stereotaxically in each lateral geniculate body ( A6.5, L10.0, H2.0 ) ( Berman 1968 ) to record the geniculate component of the PPT sites, control saline microinection sessions were given first, with the second, third, and fourth microinjections being glutamate. PGO waves. Monopolar electrodes were implanted bilaterally in the dorsal cervical neck muscles to record the electromyogram In the other six PPT sites, the first, second, and third microinjections were glutamate and the fourth was control saline. At the end ( EMG ) . These four variables ( EEG, EMG, EOG, and PGO waves ) were used to score W and sleep stages. In addition, bilat-of all experimental sessions and before perfusion, with the use of the same injector used for glutamate microinjection, 0.25 ml of eral stainless steel guide tubes ( 26 gauge ) were stereotaxically implanted 5 mm above the PPT ( AP0.5 to 00.5, L3.5 -4.0, H02.0 black ink was microinjected 1 mm dorsal to each injection site for staining solution, dehydrated, cleared, mounted, and coverslipped TABLE 1. Sequences of pedunculopontine tegmentum with the use of Permount. All histological sections were examined microinjection trials under the microscope to localize the injection sites and the NADPH-diaphorase-positive PPT cells.
Site First Injection Second Injection Third Injection Fourth Injection
A total of 48 microinjections was made in 12 PPT injec-
tion sites. Histological identification showed that 8 of the
12 sites were placed within NADPH-diaphorase-positive cell
compartments ( Figs. 1 and 2) , and thus were considered to
be within the cholinergic cell compartments of the PPT. The
remaining four injection sites were placed into NADPH-
PPT. Only glutamate injections placed in the cholinergic
compartment of PPT increased the cortical activated states of W and REM sleep. Because the four glutamate injections Each PPT site received 1 control saline (C) injection and 3 L-glutamate into noncholinergic PPT regions did not cause changes in (L-glut.) injections in 4 different recording sessions 48 h apart. All microin-W or REM sleep, those results were not included in the jections were 0.25 ml in volume (0.25 ml saline without glutamate or glutamate in 0.25 ml saline).
analyses of the data. The analysis below quantifies the effects of differing concentrations of glutamate injected into the PPT cholinergic cell compartment on the W, S, and REM localizing glutamate injection sites. In Fig. 1A , the arrow points to the ink injection mark. Thus the true position of the glutamate sleep states.
injection is 1 mm below the ink mark.
Effects of glutamate on W state Scoring and analysis of behavioral states
After glutamate microinjections, behavioral and polygraphic signs of W (Fig. 3A ) did not show any significant Polygraphic data were scored for W, S state 1 (S1), S state 2 qualitative differences compared with behavioral and poly-(S2), S with PGO waves (SP), and REM sleep according to graphic signs of W following control saline injections (Fig. standard criteria (Datta 1995; Datta and Hobson 1994, 1995; Ursin 3B). Quantitatively, 3.0-mg doses of glutamate applied into and Sterman 1981). All states were scored in 15-s epochs, yielding the cholinergic cell compartments of the PPT produced short, a total of 960 bins after each microinjection trial. The polygraphic and behavioral measures provided the following dependent vari-robust changes in the percentage of time spent in W comables that were quantified for each microinjection trial: 1) percentpared with microinjections of control saline. Analysis across age of recording time spent in W, S1, S2, SP, and REM sleep per the entire duration of the recording sessions provides only hour and 2) latency to onset of the first episode of REM sleep a limited picture because of glutamate's short duration of after the onset of injection. Statistical analyses were performed effect. Therefore analyses were performed with the recording with the use of StatView statistical software (Abacus Concepts, sessions divided into four 1-h periods. Because all microin- Berkeley, CA, 1994) . Analyses of variance and paired t-tests were jections were made during W, there was no measure of W used to examine the effects of microinjection of glutamate versus latency. As shown in Fig. 4 , microinjection of 0.3 and 1.0 control saline on behavioral states of W, S1, S2, SP, and REM mg glutamate into the cholinergic cell compartments of the sleep.
PPT did not change the percentage of time in W compared with control microinjection of saline into the same sites.
Histological localization of injection sites
When the concentration of injected glutamate was increased At the conclusion of the microinjection experiments, cats were to 3.0 mg, animals spent the first 2 h in W. Compared with deeply reanesthetized with pentobarbital sodium (50 mg/kg iv) the control microinjection, the glutamate-induced changes and perfused transcardially with heparinized cold phosphate buffer were highly significant both during the 1st h (df Å 7; t Å (0.1 M, pH 7.4) followed by 4% paraformaldehyde in 0.1 M phos-013.62; P Å 0.0001) and the 2nd h (df Å 7; t Å 042.48; phate buffer. The brains were removed, and trimmed brain stem P Å 0.0001) of postinjection recording. During the 3rd h, blocks were postfixed for 3-4 h in the paraformaldehyde phosphate W was 46.00 { 5.45% (mean { SD), but these changes buffer perfusion fluid. Trimmed brain stem blocks were then stored were still significantly (df Å 7; t Å 06.69; P Å 0.0003) overnight in a solution of 0.1 M phosphate buffer and 5% sucrose higher than the 3rd h postcontrol saline injection value as a cryoprotectant. The brains were then cut in the transverse (27.50 { 3.96%). Four hours after glutamate application, plane in 40-mm-thick sections with the use of a freezing microtome.
To visualize the cholinergic neurons in the PPT, sections were the W percentage (24.86 { 3.18%) came back to its control stained for nicotinamide-adenine dinucleotide phosphate (NADPH)level (28.75 { 2.92%). Because for the first 2 h the threshold diaphorase. Free floating sections were then incubated at 37ЊC in dose of glutamate (3.0 mg) saturated the percentage of time a solution made up of 50 ml of 0.1 M phosphate buffer (pH 7.4) spent in W, the data on W were not subjected to further containing 100 mg of NADPH, 45 mg Nitro Blue Tetrazolium, analysis of frequency and duration of individual episode. and 6 ml dimethyl sulfoxide (Sandell et al. 1986 or eliminated S for 2-3 h of postinjection recording. To were not significantly different when compared with their control values. Similarly, 1.0 mg glutamate significantly re-demonstrate glutamate-induced changes in S, the percentage of time after glutamate application spent in S was compared duced the percentage of time spent in S1 (5.23 { 1.28%; df Å 7; t Å 10.17; P Å 0.0001) compared with the 1st h with control measurements obtained after saline injection. control value. Again, postinjection values for the percentage S1. The beginning of S1 is recognized by the presence of of S1 during the 2nd, 3rd, and 4th h after application of 1.0 spindling in the cortical EEG. The effects of microinjection mg glutamate were not significantly different when compared of different doses of glutamate on the percentage of time with the control values. As the dose of glutamate microinjecspent in S1 are summarized in Fig. 5 . A dose-dependent tion was increased to 3.0 mg, S1 sleep was completely elimireduction in the percentage of time spent in S1 after glutanated during the first 2 h of recording. But, during the 3rd mate microinjection was only evident during the 1st h of and 4th h of postinjection recording, S1 sleep returned to its recording. The mean percentages of time spent in S1 after control level. control injections of saline were 24.75 { 5.82% (mean { SD), 4.75 { 1.83%, 26.25 { 5.73%, and 23.50 { 6.67% S2. The deep stage of S in the cat is called S2. During this stage cortical EEG shows high-amplitude, low-frequency during postinjection recordings of the 1st, 2nd, 3rd, and 4th h, respectively. After the application of 0.3 mg glutamate, ( synchronized ) waves. The effects of microinjection of different doses of glutamate on the percentage of time spent in the S1 percentage during the 1st h dropped to 20.00 { 4.90%, and this reduction was slightly significant (df Å 7; t Å 2.04; S2 are summarized in Fig. 6 . During the control recording period, the percentage of time spent in S2 increased slowly P Å 0.08) compared with its control value. The percentage of S1 values during the 2nd, 3rd, and 4th h of recording throughout the 4 h of recordings. The control percentages tion, REM sleep began to reappear, but the total percentage of REM sleep (9.14 { 5.28%) was significantly less (df Å When the glutamate dosage was increased to 1.0 mg, the latency of REM sleep was further reduced to 24.54 { 3.55 7; t Å 3.935; P Å 0.0058) compared with its control saline value. During the 4th h, this REM sleep percentage min. This reduction was highly significant (df Å 7; t Å (20.13 { 5.44%) returned to its control level. 7.623; P Å 0.0001) compared with REM sleep latency after control saline injection. Increased glutamate dosages also Figure 9 shows representative polygraphic signs of REM sleep after control saline (Fig. 9A) (mg) . Saline: values for saline-injected controls. Note that wakefulness increased with 3.0-mg doses and did not change with 0.3-and 1.0-mg doses. Percentage of time spent in wakefulness for every h after microinjection of each dose of L-glutamate is compared with saline-injected control; asterisks indicate statistically significant differences. Double asterisk: P õ 0.001. Triple asterisk: P õ 0.0001. jections (Fig. 9B) 
into the cholinergic cell compartment of D I S C U S S I O N the PPT. Behavioral and polygraphic signs of REM sleep
The principal findings of this study are that 1) microinjecafter glutamate application resembled those signs during tion of low and medium dosages of the excitatory amino REM sleep after control saline microinjections. During REM acid L-glutamate into the cholinergic cell compartment of sleep, cortical EEG is activated (desynchronized), and is similar to a cortical EEG during W.
the PPT increases the total amount of REM sleep, and 2) a FIG . 5. Effect of saline and 3 doses of Lglutamate on % (mean { SD) of slow-wave sleep state 1 (S1). Note dose-dependent decrease of S1 after L-glutamate microinjection. Percentage of time spent in S1 for every h after microinjection of each dose of L-glutamate was compared with saline-injected controls; asterisks indicate statistically significant differences. higher dosage of L-glutamate increases the total amount of injections of L-glutamate to increase the activity of cells located within the cholinergic cell compartments of the PPT. wakefulness when injected into the same site. As a consequence of this glutamate-induced increase in wakefulness In the study of the structure-function relationship at the system level, cerebral microinjection of the excitatory amino and REM sleep, S is suppressed and/or eliminated. The results show for the first time that the excitation of the cholin-acid L-glutamate has certain advantages over traditional lesion and electrical stimulation techniques, especially in the ergic cells of the PPT causes wakefulness and/or REM sleep depending on levels of activity relative to baseline. The re-study of the wake-sleep cycle. Local application of L-glutamate excites mostly cell bodies of that particular diffusion sults presented here strengthen and extend the hypothesis that the activity of PPT cholinergic cells is important for the site, but electrolytic lesion and electrical stimulation includes not only a larger area, it also includes processes of the cell generation of REM sleep as well as wakefulness (Datta 1995 (Datta , 1997 .
body and fibers passing through that particular region (Mayer and Westbrook 1987; ). The level of excitation of a population of neurons (multiunit activity) Methodological considerations could be changed in a dose-dependent manner by changing the concentration of injected L-glutamate (Mayer and West-We chose to study freely moving unanesthetized cats unbrook 1987). Thus L-glutamate application to excite particuder chronic conditions because this preparation provides for lar cell groups that affect wake-sleep patterns could be accuthe most physiological approach to a longitudinal analysis rately evaluated for causality. of the behavioral and electrographic events related to the A major limitation of the L-glutamate microinjection method wake-sleep cycle (Siegel 1979; Siegel and McGinty 1977) .
relates to the diversity in the neurochemical nature of the neu-After the habituation period of each experimental condition, ronal population affected by the application (Mayer and Westthe cats demonstrated regular values of W and sleep stages. brook 1987). L-glutamate is a nonspecific excitatory amino Thus pharmacological manipulations that affected electroacid that excites all types of neuronal cells with different neurographic signs of wake-sleep patterns could be evaluated acchemical signatures. In this study, we injected glutamate into curately.
the part of the PPT where most cells are cholinergic (Jones Current concepts of brain stem cholinergic cells ' involveand Beaudet 1987; ; Vincent and Reiner ment in behavioral state control are based in large part on 1987). But we acknowledge that if there are noncholinergic spontaneous activity patterns of PPT cells across the wakecells within those cholinergic cell groups, they would also be sleep cycle (Datta 1995) . Modulation of these PPT cholinerexcited by the application of glutamate. gic cells' activity correlates highly with changes in behavioral state, but is not definitive evidence of causality. Barring Anatomic considerations more direct evidence, the correlative behavior of PPT cholinergic neurons across states cannot be considered as causative
With the use of specific monoclonal antibodies to choline acetyltransferase (ChAT), the laterodorsal tegmental nu-with complete confidence. In this study, we used local micro-j817-6 / 9k13$$ju08 08-05-97 09:44:19 neupas LP-Neurophys cleus and PPT have been shown to be the major aggregations diaphorase activity (Vincent et al. , 1986 . Thus mesopontine NADPH-diaphorase-positive cells are unequivocally of cholinergic neurons in the mammalian brain stem (Armstrong et al. 1983; Jones and Beaudet 1987; Kimura et al. considered to be the cholinergic cells (Luebke et al. 1992 (Luebke et al. , 1993 Steriade et al. 1990; Vincent et al. , 1986 Wil-1981; Mesulam et al. 1983 Mesulam et al. , 1984 Mesulam et al. , 1989 Satoh and Fibiger 1985; . All liams and Reiner 1993). All of our eight positive injection sites were located within the cluster of NADPH-diaphorase-of these ChAT-positive cells also displayed intense NADPH- positive cells of the PPT at stereotaxic levels A0.5-P0.5. In support of our suggestion, one earlier electrical stimula-At this stereotaxic level 95% of those cells are cholinergic tion study has shown that the stimulation of PPT cells Steriade et al. 1990 ; Webster and in an anesthetized preparation releases ACh ( Lydic and Jones 1988) . Four other injection sites were close to these Baghdoyan 1993 ) . positive sites but were not effective in changing electro-In the last decade, evidence has accumulated indicating graphic events related to the wake-sleep cycle. In fact, in that each of the events of REM sleep is generated by distinct these injection sites, very few cells were NADPH-diaphorase cell groups in the brain stem (reviewed in Datta 1995). positive. These results indicate that electrographic changes Although these cell groups are distinct, they are components in the wake-sleep cycle observed after glutamate microinjecof a widely distributed network (Datta and Hobson 1994, tion into the PPT were mainly due to the excitation of cholin-1995; Jones 1991; Morrison 1979; Sakai 1985; Vertes ergic cells. 1984 cells, resulting in release of ACh into all of the above REM-the mesencephalic cholinergic neurons would induce wakefulness (Datta 1995) . The results of the present study dem-sleep-sign-generating structures of the brain stem.
Neuroanatomic studies in which retrograde tracers were onstrate that a higher dose of L-glutamate microinjection into the cholinergic cell compartments of the PPT induces used have shown that the axons of PPT cholinergic cells project to the REM-sleep-sign-generating structures of the wakefulness. This finding directly supports the hypothesis that the maximal level of activity of the cholinergic neurons brain stem (Jones 1991; Leichnetz et al. 1989; Mitani et al. 1988; Semba 1993; Semba et al. induces and sustains wakefulness. 1990; . These anatomic connectivity
To explain the observation, we suggest that the high dose studies indicate that the PPT cholinergic cells could release of L-glutamate maximally activates PPT cholinergic cells. ACh to the cholinoceptive REM-sleep-generating structures Maximal excitation of cholinergic cells released ACh to the of the brain stem. The present study also suggests that the locus coeruleus and other structures involved in wakefulness. glutamatergic stimulation of the PPT cholinergic cells ex-It is already known that the locus coeruleus receives afferent cites REM-sleep-sign-generating cells by releasing ACh and inputs from the PPT cholinergic cells (Jones 1991; McBride ultimately induces REM sleep. In support of this suggestion, and Sutin 1976; . It is also known that several studies have shown that the local microinjection of the cholinergic agonist directly excites locus coeruleus cells cholinomimetics into the many discrete parts of the pons (Berridge and Foote 1991). Excitation of the locus coeruleus evoke a state that is behaviorally and electrophysiologically noradrenergic cells causes inhibition of REM-sleep-signsimilar to REM sleep (Baghdoyan et al. 1993; Baxter 1969 ; generating cells and ultimately causes wakefulness (Aston-Chase and Morales 1990; Datta et al. 1992; Gnadt and Pe-Jones and Bloom 1981; Hobson et al. 1975; Karczmar et al. gram 1986; Mitler and Dement 1974; Vanni-Mercier et al. 1970; McCarley and Hobson 1975 Williams and Reiner 1993) . its respective triggering structure in the brain stem (Datta 1996; Datta et al. 1991 Datta et al. , 1992 Magherini et al. 1971; Nunez Role of the PPT in cortical activation et al. 1991; Reid et al. 1994; Vertes et al. 1993) .
Another line of evidence supporting the notion that the Cortical activation is a prerequisite for perceptual pro-PPT neurons are involved in the generation of REM sleep cesses and purposeful behaviors. The replacement of highcomes from extracellular single-cell recording studies (Datta amplitude synchronized EEG waves by low-voltage, high-1995; Datta et al. 1989; El-Mansari et al. 1989 1953; Dement and Kleitman 1957) . The in PGO wave density after glutamatergic excitation of the cellular, molecular, and network mechanisms for cortical PPT cells. To our surprise, we did not observe any differactivation are different during wakefulness and REM sleep ences in PGO wave density or any state-independent PGO (reviewed and modeled in Datta 1995). waves after glutamatergic stimulation. This observation sug-Given the long-term association of ACh with neocortical gests that activation of PPT cells alone is insufficient to activation or arousal (Celesia and Jasper 1966; Jasper and induce PGO waves; however, it seems clear that these cells Tessier 1971 ; Longo 1966; Szerb 1967; Wikler 1952) , very do play an important role in PGO wave generation and modlittle research has been directed toward the contribution of ulation (Datta 1997; Datta and Hobson 1994) . the brain stem cholinergic system to neocortical activation (Datta 1995; Steriade et al. 1990; Williams et al. 1994 ).
Role of the PPT in wakefulness
Single-cell recording studies in behaving cats have shown that a group of PPT cholinergic cells is active both during At present there are only two lines of evidence implicating wakefulness and REM sleep. These cells' firing rates began involvement of the PPT cholinergic cells in wakefulness.
to increase 20-60 s before the onset of both wakefulness The first comes from extracellular single-cell recording studand REM sleep in the transition from S (reviewed in Datta ies. One group of PPT cholinergic cells is active both during 1995). The increased neuronal activity of the PPT cholinerwakefulness and REM sleep (Datta 1995; Datta et al. 1989;  gic cells that heralds cortical (EEG) activated states (wake-El- Mansari et al. 1989; Saito et al. 1977 ). These cells have fulness and REM sleep) implicates these neurons as causal a much higher firing rate during active W than during REM elements for the cortical activation. By demonstrating that sleep. The second line of evidence comes from local microinglutamatergic stimulation of PPT cholinergic cells increases jection studies. Microinjection of a cholinergic agonist into cortically activated states of wakefulness and REM sleep by the locus coeruleus excites noradrenergic cells and activates suppressing S, the present study supports the idea that PPT cortical EEG (Berridge and Foote 1991). From these studies, we hypothesized that the maximal level of activity of cholinergic cells are causal to the cortical activation. 
